Secret Dry Spray Antiperspirant Recalled Over Manufacturing Facility Defect
Secret Dry Spray antiperspirant is being recalled due to CGMP violations at the manufacturing facility where other lots were found contaminated with benzene. No illnesses have been reported.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for CGMP violations and facility contamination with benzene, a high-risk hazard. No illnesses or injuries have been reported, making this a theoretical risk-of-harm situation that meets the High severity criterion.
Plain-English summary
The Procter & Gamble Company is recalling Secret Dry Spray antiperspirant (Rose scent, 3.8 oz, NDC 69423-380-10) due to current Good Manufacturing Practice (CGMP) deviations identified at the manufacturing facility.
Other lots manufactured at the same facility were found to be contaminated with benzene. This recall affects products with lot codes expiring through September 2023.
The product has been distributed nationwide in the USA and Puerto Rico, as well as internationally in Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, and Guyana. Consumers should stop using the affected product immediately.
The recalled product
- Product
- Secret Dry Spray, Aluminum chlorohydrate 23.5%, Antiperspirant, Rose, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-380-10, UPC 0 37000 79884 2
- Manufacturer
- The Procter & Gamble Company
- Category
- Drug — Antiperspirant / Topical
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots with expiry through September 2023
Distribution
Part of a larger recall action
This product is one of 19 recalled by The Procter & Gamble Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same manufacturer · The Procter & Gamble Company
See all →- ModeratePsyllium Fiber Capsules Recalled Due to Illegible Labeling
FDA (Food) · 2024-02-28
- HighSecret anti-perspirant spray recalled for potential benzene contamination
FDA (Drugs) · 2024-01-24
- SevereOld Spice Anti-Perspirant Spray Recalled Due to Benzene Contamination
FDA (Drugs) · 2024-01-24
- HighSecret OUTLAST Dry Spray Antiperspirant Recalled for Benzene Contamination
FDA (Drugs) · 2024-01-24
- SevereOld Spice Sweat Defense Spray Recalled for Benzene Contamination Nationwide
FDA (Drugs) · 2024-01-24
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateAntiperspirant spray recalled over contamination found elsewhere at the facility
FDA (Drugs) · 2025-11-26
- ModeratePower Stick Spring Fresh roll-on antiperspirant recalled over manufacturing deviations
FDA (Drugs) · 2025-07-23
- ModeratePower Stick for her roll-on antiperspirant recalled over manufacturing deviations
FDA (Drugs) · 2025-07-23
- SevereSure Regular Antiperspirant Deodorant Aerosol Recalled for Benzene Contamination
FDA (Drugs) · 2024-01-03
- ModeratePower Stick roll-on antiperspirant recalled over manufacturing practice deviations
FDA (Drugs) · 2025-07-23
- HighSuave Aerosol Antiperspirant Recalled for Potential Benzene Contamination
FDA (Drugs) · 2022-05-04